Page last updated: 2024-12-05

t 0509

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

RP333: RN given refers to (+-)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID173382
SCHEMBL ID3690949
MeSH IDM0084559

Synonyms (12)

Synonym
gtpl533
rp333
L000586
4-[2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]benzene-1,2-diol
1,2-benzenediol, 4-(2-((2-(3,4-dimethoxyphenyl)ethyl)amino)-1-hydroxyethyl)-,
t 0509
t-0509
SCHEMBL3690949
4-(2-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-hydroxyethyl)benzene-1,2-diol
DTXSID30996720
Q27088907
96843-99-1

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" for 6 days shifted the dose-response curves of isoproterenol (i."( Desensitization and selective down-regulation of rat cardiac beta 1-adrenoceptors by prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor full agonist.
Adachi-Akahane, S; Imai, K; Nagao, T; Prados, P; Sato, Y, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346260Human beta1-adrenoceptor (Adrenoceptors)1996European journal of pharmacology, Nov-21, Volume: 315, Issue:3
Molecular characterization of pharmacological properties of T-0509 for beta-adrenoceptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's16 (84.21)18.2507
2000's2 (10.53)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]